Optimized Administration of the M4 PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mecp2 +/– Mice
Cikowski, Jakub, Holt, Calista, Arthur, Bright, Smith, Mackenzie, Gonzalez, Sonia, Lindsley, Craig W., Niswender, Colleen M., Gogliotti, Rocco G.
Published in ACS chemical neuroscience (06.07.2022)
Published in ACS chemical neuroscience (06.07.2022)
Get full text
Journal Article
Clinical and Preclinical Evidence for M 1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome
Smith, Mackenzie, Arthur, Bright, Cikowski, Jakub, Holt, Calista, Gonzalez, Sonia, Fisher, Nicole M, Vermudez, Sheryl Anne D, Lindsley, Craig W, Niswender, Colleen M, Gogliotti, Rocco G
Published in Neurotherapeutics (01.07.2022)
Published in Neurotherapeutics (01.07.2022)
Get full text
Journal Article
Optimized Administration of the M 4 PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mecp2 +/ - Mice
Cikowski, Jakub, Holt, Calista, Arthur, Bright, Smith, Mackenzie, Gonzalez, Sonia, Lindsley, Craig W, Niswender, Colleen M, Gogliotti, Rocco G
Published in ACS chemical neuroscience (06.07.2022)
Published in ACS chemical neuroscience (06.07.2022)
Get full text
Journal Article
Clinical and Preclinical Evidence for M1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome
Smith, Mackenzie, Arthur, Bright, Cikowski, Jakub, Holt, Calista, Gonzalez, Sonia, Fisher, Nicole M., Vermudez, Sheryl Anne D., Lindsley, Craig W., Niswender, Colleen M., Gogliotti, Rocco G.
Published in Neurotherapeutics (01.07.2022)
Published in Neurotherapeutics (01.07.2022)
Get full text
Journal Article